CPDA-1 155 mg/70mL (Anticoagulant Citrate Phosphate Dextrose Adenine SOLUTION) 155 mg/70mL

CPDA-1 155 mg/70mL is an anticoagulant solution used to preserve blood components. This intravenous solution contains citrate, phosphate, dextrose, and adenine, designed for medical use. Ideal for maintaining blood viability during storage.

Strength

155 mg/70mL

Pack Size

70 mL in 1 BAG (0942-6308-02)

Manufacturer / TM Owner

Fenwal, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

CPDA-1 155 mg/70mL is primarily used to prevent blood clotting in collected blood. This solution is often employed in blood banks and medical facilities to extend the shelf life of stored blood. It is commonly used in procedures requiring blood transfusions, ensuring the blood remains viable for longer periods. What is CPDA-1 used for? It helps maintain the quality and safety of blood products.

Side Effects

The primary effect of CPDA-1 155 mg/70mL is to inhibit clotting in collected blood. This solution also provides nutrients that help preserve red blood cells. Users may notice that blood stored with this solution remains stable and suitable for transfusion over an extended period.

Precautions & Warnings

Handle CPDA-1 155 mg/70mL with care, ensuring it is stored according to manufacturer guidelines. Always check for any visible signs of contamination before use. Follow standard protocols for intravenous solutions to maintain safety and efficacy.

Avoid Interactions

CPDA-1 155 mg/70mL may interact with certain medications or substances. Consult healthcare professionals before combining it with other treatments. Be aware of potential interactions with other intravenous solutions or blood products.

Frequently Asked Questions

CPDA-1 155 mg/70mL is used to prevent blood clotting and preserve blood components during storage.

Store CPDA-1 155 mg/70mL according to the manufacturer's instructions, typically in a cool, dry place.

Consult a healthcare professional before combining CPDA-1 155 mg/70mL with other medications.

CPDA-1 155 mg/70mL contains citrate, phosphate, dextrose, and adenine.

CPDA-1 155 mg/70mL is generally suitable for all blood types, but specific compatibility should be confirmed with a healthcare professional.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.